register

News & Trends - MedTech & Diagnostics

Surgeons’ caseload linked to patient outcomes in joint replacement surgery

Health Industry Hub | June 23, 2023 |

MedTech & Diagnostics News: Patients treated by surgeons who perform over 10 shoulder replacements annually experience significantly lower risks of reoperation and serious complications. Furthermore, these patients enjoy shorter hospital stays compared to those treated by surgeons who conduct fewer operations.

This latest research builds upon previous findings related to hip and knee replacements, further solidifying the crucial role of surgeon expertise in ensuring successful outcomes for patients. The study’s authors emphasise that these findings should guide future resource planning in the field of joint replacement surgery.

The global prevalence of shoulder replacements has been steadily increasing, particularly in high-income countries where aging populations are becoming more common. While prior investigations focused on hip and knee replacements highlighted the advantages of having surgery conducted by “high-volume” surgeons, evidence for other types of joint replacement procedures has remained limited. This knowledge gap prompted a team of researchers to delve into the association between surgeon volume and outcomes specifically in non-urgent (elective) shoulder replacement surgeries.

SAVE THE DATE - Health Industry Hub Awards Night 2023

To gather comprehensive data, the researchers analysed information from 39,281 elective shoulder replacements carried out by 638 consultant surgeons across 416 public and private hospitals from 2012 to 2020.

The researchers identified a significant mean annual volume threshold of 10.4 procedures. Surgeons who performed at least this number of procedures annually demonstrated a remarkable 45% lower risk of revision surgery compared to their counterparts who conducted fewer procedures.

Patients treated by higher volume surgeons also exhibited a 53% lower risk of reoperation, along with reductions in serious adverse events (40% at 30 days and 37% at 90 days) and a 62% decreased risk of prolonged hospital stays. However, no minimum case volume threshold was identified for these particular outcomes.

Interestingly, the study found that annual variations in case volume did not impact patient outcomes significantly. This suggests that a surgeon’s average annual volume of procedures throughout their career plays a more substantial role in enhancing patient outcomes than yearly fluctuations in procedure volumes.

The authors emphasise the importance of improving outcomes and reducing complications in joint replacement surgeries for the benefit of patients and their families. Additionally, they argue that these results are particularly valuable for healthcare systems currently burdened and in need of recovery planning in the aftermath of the COVID-19 pandemic.

In conclusion, the researchers state that their study offers crucial evidence for local hospitals and national healthcare services, facilitating informed workforce and resource planning to ensure the best possible outcomes for patients undergoing shoulder replacement surgery.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.